Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exozymes (EXOZ) Shares Outstanding (Weighted Average) (2023 - 2024)

Exozymes (EXOZ) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $6.3 million as the latest value for Q3 2024.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.02% to $6.3 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Sep 2024, changed 0.02% year-over-year, with the annual reading at $6.3 million for FY2023, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2024 was $6.3 million at Exozymes, roughly flat from $6.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $6.3 million in Q3 2024, with the low at $6.3 million in Q3 2023.